Literature DB >> 9482215

Lipopolysaccharide and pneumococcal cell wall components activate the mitogen activated protein kinases (MAPK) erk-1, erk-2, and p38 in astrocytes.

R R Schumann1, D Pfeil, D Freyer, W Buerger, N Lamping, C J Kirschning, U B Goebel, J R Weber.   

Abstract

Cell wall compounds of gram-positive bacteria are capable of inducing the biosynthesis of proinflammatory cytokines in CNS cells in a similar way as lipopolysaccharide (LPS) of gram-negative bacteria does. Astrocytes, which lack the CD14 LPS receptor, have also been shown to respond to LPS-stimulation by increased cytokine synthesis. However, almost nothing is known about signaling steps involved in this process. We have therefore examined signaling events in primary cultures of rat astrocytes and the human astrocytoma cell line U373MG, brought about by LPS and pneumococcal cell walls (PCW). Of particular interest to us was the tyrosine phosphorylation patterns and activation states of three members of the mitogen activated protein kinase (MAPK) family, i.e., extracellular signal-regulated protein kinase (erk)-1, erk-2, and the recently identified p38. We show that LPS and PCW initiate tyrosine phosphorylation and activation of erk-1, erk-2, and p38 in a dose-dependent fashion. Inhibitors of tyrosine phosphorylation were able to alleviate this effect and also blocked cytokine production of astrocytes. Both, LPS- and PCW-induced responses of astrocytic cells required the presence of soluble CD14 (sCD14) present in serum. Unraveling the signaling steps induced by bacterial compounds in cells of the CNS may potentially help to elucidate the pathomechanisms of meningitis and central nervous complications of sepsis and may offer options for novel treatment strategies.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9482215     DOI: 10.1002/(sici)1098-1136(199803)22:3<295::aid-glia8>3.0.co;2-4

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  14 in total

Review 1.  The role of Toll-like receptors in CNS response to microbial challenge.

Authors:  Gregory W Konat; Tammy Kielian; Ian Marriott
Journal:  J Neurochem       Date:  2006-08-08       Impact factor: 5.372

2.  Low-density lipoprotein receptors regulate microglial inflammation through c-Jun N-terminal kinase.

Authors:  Ana Pocivavsek; Mark P Burns; G William Rebeck
Journal:  Glia       Date:  2009-03       Impact factor: 7.452

3.  beta-Arrestin 1 participates in platelet-activating factor receptor-mediated endocytosis of Streptococcus pneumoniae.

Authors:  Jana N Radin; Carlos J Orihuela; Gopal Murti; Christopher Guglielmo; Peter J Murray; Elaine I Tuomanen
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

4.  The MEK/ERK pathway is the primary conduit for Borrelia burgdorferi-induced inflammation and P53-mediated apoptosis in oligodendrocytes.

Authors:  Geetha Parthasarathy; Mario T Philipp
Journal:  Apoptosis       Date:  2014-01       Impact factor: 4.677

5.  Immunostimulation by the synthetic lipopeptide P3CSK4: TLR4-independent activation of the ERK1/2 signal transduction pathway in macrophages.

Authors:  M R Müller; S D Pfannes; M Ayoub; P Hoffmann; W G Bessler; K Mittenbühler
Journal:  Immunology       Date:  2001-05       Impact factor: 7.397

6.  Essential role for verotoxin in sustained stress-activated protein kinase and nuclear factor kappa B signaling, stimulated by Escherichia coli O157:H7 in Vero cells.

Authors:  Pamela Cameron; Deborah Bingham; Andrew Paul; Martin Pavelka; Scott Cameron; Dino Rotondo; Robin Plevin
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

7.  NOD2 mediates inflammatory responses of primary murine glia to Streptococcus pneumoniae.

Authors:  Xinjie Liu; Vinita S Chauhan; Amy B Young; Ian Marriott
Journal:  Glia       Date:  2010-05       Impact factor: 7.452

8.  Tetrandrine suppresses LPS-induced astrocyte activation via modulating IKKs-IkappaBalpha-NF-kappaB signaling pathway.

Authors:  Shu-Ting Lin; Ying Wang; Yang Xue; De-Chun Feng; Yan Xu; Ling-Yun Xu
Journal:  Mol Cell Biochem       Date:  2008-05-23       Impact factor: 3.396

9.  Tyrosine kinase inhibition reduces inflammation in the acute stage of experimental pneumococcal meningitis.

Authors:  Klemens Angstwurm; Uwe-Karsten Hanisch; Tarraneh Gassemi; Margrethe Bastholm Bille; Marco Prinz; Ulrich Dirnagl; Helmut Kettenmann; Joerg R Weber
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

10.  Neuronal effects of 4-t-Butylcatechol: a model for catechol-containing antioxidants.

Authors:  Yi-Ching Lo; Yuxin Liu; Yi-Chin Lin; Yu-Tzu Shih; Chi-Ming Liu; Leo T Burka
Journal:  Toxicol Appl Pharmacol       Date:  2007-12-14       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.